Literature DB >> 14507674

Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice.

Rien van Haperen1, Caroline Cheng, Barend M E Mees, Elza van Deel, Monique de Waard, Luc C A van Damme, Teus van Gent, Thijs van Aken, Rob Krams, Dirk J Duncker, Rini de Crom.   

Abstract

The activity of endothelial nitric oxide synthase (eNOS) is subject to complex transcriptional and post-translational regulation including the association with several proteins and variations in subcellular distribution. In the present study we describe a transgenic mouse model expressing eNOS fused to green fluorescent protein (GFP), which allows the study of localization and regulation of eNOS expression. We tested the functionality of eNOS in the eNOS-GFP mice. Expression of eNOS was restricted to the endothelial lining of blood vessels in various tissues tested, without appreciable expression in non-endothelial cells. Activity of the enzyme was confirmed by assaying the conversion of L-arginine to L-citrulline. NO production in isolated vessels was increased in transgenic mice when compared to non-transgenic control animals (4.88 +/- 0.59 and 2.48 +/- 0.47 micro mol/L NO, respectively, P < 0.005). Both the mean aortic pressure and the pulmonary artery pressure were reduced in eNOS-GFP mice (both approximately 30%, P < 0.05). Plasma cholesterol levels were also slightly reduced ( approximately 20%, P < 0.05). In conclusion, eNOS-GFP mice express functional eNOS and provide a unique model to study regulation of eNOS activity or eNOS-mediated vascular events, including response to ischemia, response to differences in shear stress, angiogenesis and vasculogenesis, and to study the subcellular distribution in relation with functional responses to these events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507674      PMCID: PMC1868317          DOI: 10.1016/S0002-9440(10)63524-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Inhaled nitric oxide.

Authors:  William E Hurford
Journal:  Respir Care Clin N Am       Date:  2002-06

2.  Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion.

Authors:  Jessica Lie; Rini de Crom; Teus van Gent; Rien van Haperen; Leo Scheek; Inge Lankhuizen; Arie van Tol
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

Review 3.  Primary pulmonary hypertension: Current therapy.

Authors:  Olivier Sitbon; Marc Humbert; Gérald Simonneau
Journal:  Prog Cardiovasc Dis       Date:  2002 Sep-Oct       Impact factor: 8.194

Review 4.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

Authors:  D Fulton; J P Gratton; W C Sessa
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

5.  Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme.

Authors:  David Fulton; Jason Fontana; Grzegorz Sowa; Jean-Philippe Gratton; Michelle Lin; Kai-Xun Li; Belinda Michell; Bruce E Kemp; David Rodman; William C Sessa
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

6.  Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein.

Authors:  Rien van Haperen; Arie van Tol; Teus van Gent; Leo Scheek; Pim Visser; Arthur van der Kamp; Frank Grosveld; Rini de Crom
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

7.  Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.

Authors:  William Schubert; Philippe G Frank; Scott E Woodman; Hideyuki Hyogo; David E Cohen; Chi-Wing Chow; Michael P Lisanti
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

8.  NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase.

Authors:  Kirstin Zimmermann; Nils Opitz; Jurgen Dedio; Christoph Renne; Werner Muller-Esterl; Stefanie Oess
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-21       Impact factor: 11.205

Review 9.  Regulation of endothelial nitric oxide synthase activity and gene expression.

Authors:  Kenneth K Wu
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

10.  Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide.

Authors:  Rien van Haperen; Monique de Waard; Elza van Deel; Barend Mees; Michael Kutryk; Thijs van Aken; Jaap Hamming; Frank Grosveld; Dirk J Duncker; Rini de Crom
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

View more
  25 in total

1.  Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.

Authors:  Yehua Gan; Ying H Shen; Jian Wang; Xinwen Wang; Budi Utama; Jing Wang; Xing Li Wang
Journal:  J Biol Chem       Date:  2005-02-19       Impact factor: 5.157

2.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

Review 3.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Role of nitric oxide in murine conventional outflow physiology.

Authors:  Jason Y H Chang; W Daniel Stamer; Jacques Bertrand; A Thomas Read; Catherine M Marando; C Ross Ethier; Darryl R Overby
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-03       Impact factor: 4.249

5.  Two functionally distinct pools of eNOS in endothelium are facilitated by myoendothelial junction lipid composition.

Authors:  Lauren A Biwer; Evan P Taddeo; Brandon M Kenwood; Kyle L Hoehn; Adam C Straub; Brant E Isakson
Journal:  Biochim Biophys Acta       Date:  2016-04-19

6.  Aerobic exercise prevents rarefaction of pial collaterals and increased stroke severity that occur with aging.

Authors:  Wojciech Rzechorzek; Hua Zhang; Brian K Buckley; Kunjie Hua; Daniel Pomp; James E Faber
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-07       Impact factor: 6.200

7.  Effect of nitric oxide on anterior segment physiology in monkeys.

Authors:  Galen W Heyne; Julie A Kiland; Paul L Kaufman; B'Ann T Gabelt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-30       Impact factor: 4.799

8.  Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure.

Authors:  K M Redding; B L Chen; A Singh; R N Re; L G Navar; D M Seth; C D Sigmund; W W Tang; J L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

Review 9.  'In vivo' optical approaches to angiogenesis imaging.

Authors:  T J A Snoeks; C W G M Löwik; E L Kaijzel
Journal:  Angiogenesis       Date:  2010-05-08       Impact factor: 9.596

Review 10.  Exercise training in adverse cardiac remodeling.

Authors:  Dirk J Duncker; Elza D van Deel; Monique C de Waard; Martine de Boer; Daphne Merkus; Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2014-02-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.